PriceTargets.com logo

Supreme Cannabis - FIRE Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00 As of 06/24/2021 12:59 AM ET
+0 (0.00%)

This chart shows the closing price for FIRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Supreme Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FIRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FIRE

Analyst Price Target is C$0.00
This price target is based on 0 analysts offering 12 month price targets for Supreme Cannabis in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.

This chart shows the closing price for FIRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Supreme Cannabis. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/17/2021CormarkBoost TargetNAC$0.35
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.08 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
Mentions as of
9/22/2023
  • 1 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
10/22/2023
  • 1 very positive mentions
  • 13 positive mentions
  • 7 negative mentions
  • 1 very negative mentions
Mentions as of
11/21/2023
  • 1 very positive mentions
  • 11 positive mentions
  • 9 negative mentions
  • 5 very negative mentions
Mentions as of
12/21/2023
  • 3 very positive mentions
  • 13 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
1/20/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
Mentions as of
2/19/2024
  • 1 very positive mentions
  • 13 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
Mentions as of
3/20/2024
  • 5 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 5 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 5 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 5 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Supreme Cannabis logo
The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: C$0.34
Low: C$0.34
High: C$0.34

52 Week Range

Now: N/A

Volume

2,099,107 shs

Average Volume

9,169,223 shs

Market Capitalization

C$259.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Supreme Cannabis?

The following equities research analysts have issued research reports on Supreme Cannabis in the last twelve months:
View the latest analyst ratings for FIRE.

What is the current price target for Supreme Cannabis?

0 Wall Street analysts have set twelve-month price targets for Supreme Cannabis in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Supreme Cannabis in the next year.
View the latest price targets for FIRE.

What is the current consensus analyst rating for Supreme Cannabis?

Supreme Cannabis currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for FIRE.

What other companies compete with Supreme Cannabis?

Other companies that are similar to Supreme Cannabis include Organigram, ESSA Pharma, ICC Labs, Cipher Pharmaceuticals and RIV Capital. Learn More about companies similar to Supreme Cannabis.

How do I contact Supreme Cannabis' investor relations team?

The company's listed phone number is 416-630-7272. The official website for Supreme Cannabis is www.supreme.ca. Learn More about contacing Supreme Cannabis investor relations.